Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.15
Delayed Data
As of 4:01pm ET
 +0.50 / +3.00%
Today’s Change
8.31
Today|||52-Week Range
32.74
+18.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues2.4B2.5B2.4B2.1B
 
 
 
 
 
Cost of Goods Sold610.3M614.5M615.3M557.0M
 
 
 
 
 
Depreciation And Amortization720.1M708.6M706.7M674.0M
 
 
 
 
 
 
Operating ExpensesGross Income1.1B1.2B1.1B878.0M
 
 
 
 
 
General Expenses795.8M761.7M758.0M757.0M
 
 
 
 
 
Other Operating Expenses4.7M1.1M0.000.00
 
 
 
Research And Development124.3M100.8M93.0M96.0M
 
 
 
 
 
Total Operating Expenses2.1B2.1B2.1B2.0B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income289.3M393.7M323.0M121.0M
 
 
 
 
 
Extraordinary Credit39.0M0.0031.0M10.0M
 
 
 
 
Extraordinary Charge-258.8M-1.3B-208.2M-300.0M
 
 
 
 
 
Interest Expense On Debt472.5M469.6M467.5M474.0M
 
 
 
 
 
Other Expenses24.1M-2.3M-40.8M345.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-376.8M-1.3B-360.0M-295.0M
 
 
 
 
 
Income Taxes-72.8M-113.3M-152.0M-924.0M
 
 
 
 
 
Minority Interest-1.7M-700.0K-3.0M-1.0M
 
 
 
 
 
Net Income-302.3M-1.2B-515.0M628.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS345.0M349.5M349.6M349.8M
 
 
 
 
 
Shares To Calculate EPS Diluted345.0M349.5M349.6M350.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.88-$3.49-$1.47$1.80
 
 
 
 
 
EPS Diluted-$0.88-$3.49-$1.47$1.79